| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.576 | 42.817 | 66.592 | 94.201 | 86.301 | 112.928 | 229.059 | 227.676 | 282.798 |
| Total Income - EUR | - | 9.996 | 45.940 | 69.933 | 96.575 | 96.916 | 133.747 | 231.335 | 228.792 | 283.408 |
| Total Expenses - EUR | - | 31.378 | 55.938 | 68.524 | 88.958 | 109.182 | 132.108 | 182.196 | 185.145 | 202.926 |
| Gross Profit/Loss - EUR | - | -21.382 | -9.998 | 1.409 | 7.617 | -12.266 | 1.639 | 49.139 | 43.647 | 80.482 |
| Net Profit/Loss - EUR | - | -21.448 | -10.426 | 742 | 6.663 | -12.875 | 336 | 46.882 | 41.368 | 72.168 |
| Employees | - | 0 | 4 | 5 | 5 | 5 | 5 | 6 | 7 | 6 |
Check the financial reports for the company - Daniamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 26.167 | 26.935 | 25.380 | 21.468 | 34.842 | 29.374 | 55.381 | 44.905 | 39.329 |
| Current Assets | - | 565 | 1.135 | 14.893 | 21.120 | 7.400 | 9.880 | 7.986 | 57.686 | 193.961 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 290 | 1.793 | 2.664 | 2.589 | 1.888 | 397 | 62.819 |
| Cash | - | 565 | 1.135 | 14.603 | 19.327 | 4.736 | 7.291 | 6.098 | 57.289 | 131.142 |
| Shareholders Funds | - | -23.080 | -33.116 | -31.766 | -24.488 | -36.898 | -35.744 | 11.027 | 41.416 | 72.216 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 51.708 | 53.692 | 65.859 | 62.054 | 75.288 | 72.282 | 50.670 | 60.561 | 161.281 |
| Income in Advance | - | 8.780 | 7.493 | 6.238 | 5.022 | 3.852 | 2.715 | 1.669 | 613 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Daniamed S.r.l.